Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Treasury Shares (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Treasury Shares for 3 consecutive years, with $500000.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $500000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $500000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $500000.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares for Q4 2025 was $2.6 million at Plus Therapeutics, down from $2.8 million in the prior quarter.
  • The five-year high for Treasury Shares was $2.8 million in Q3 2025, with the low at -$258425.0 in Q2 2024.
  • Average Treasury Shares over 3 years is $531941.9, with a median of -$78559.0 recorded in 2023.
  • The sharpest move saw Treasury Shares skyrocketed 296.83% in 2024, then changed 0.0% in 2025.
  • Over 3 years, Treasury Shares stood at $126000.0 in 2023, then surged by 296.83% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $500000.0, $500000.0, and $500000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.